$7.47
-0.12 (-1.58%)
Jazz Pharmaceuticals, Inc. (JAZZ)
CAPS Rating:
A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

RSS Headlines
Fool UK
Recs
I suspect this company got its ticker symbol before it came up with a business plan.